Artificial Intelligence | News | Insights | AiThority
[bsfp-cryptocurrency style=”widget-18″ align=”marquee” columns=”6″ coins=”selected” coins-count=”6″ coins-selected=”BTC,ETH,XRP,LTC,EOS,ADA,XLM,NEO,LTC,EOS,XEM,DASH,USDT,BNB,QTUM,XVG,ONT,ZEC,STEEM” currency=”USD” title=”Cryptocurrency Widget” show_title=”0″ icon=”” scheme=”light” bs-show-desktop=”1″ bs-show-tablet=”1″ bs-show-phone=”1″ custom-css-class=”” custom-id=”” css=”.vc_custom_1523079266073{margin-bottom: 0px !important;padding-top: 0px !important;padding-bottom: 0px !important;}”]

Resilience Capital Partners Acquires TSS Technologies

Private Equity Firm to Invest Capital in New Platform Focused on Custom Automation Solutions

Resilience Capital Partners, a private equity firm that invests in middle-market companies, announced it has acquired TSS Technologies, a third generation business that provides total automation solutions from material handling and assembly to web handling and vision inspection. TSS provides custom automation systems to many Global 50 companies in sectors that serve medical device and life sciences, consumer goods/products, industrial, as well aviation and aerospace.  Terms of the transaction were not disclosed.

Read More:  Alliance for Artificial Intelligence in Healthcare (AAIH) Sponsoring Panel at Biotech Showcase as Part of Official AAIH Launch

TSS has operations in both West Chester, OH (headquarters) and in Carlsbad, CA under the name R&3D Technologies.  Together TSS employs more than 100 professionals.  The Company’s team of engineers utilizes a combination of experience and knowledge to solve the complex challenges of process automation.  TSS specializes in implementing cutting edge technologies into any manufacturing operation and can deliver turn-key robotic cells or custom automation systems to meet its customer stringent requirements.

Related Posts
1 of 1,075

“We are excited about TSS’s bright future and look to build a leader in highly engineered custom automation solutions with a focus in the medical device and life sciences sectors,” said Bassem Mansour, co-chief executive officer of Resilience Capital Partners.

Read More:  AI Healthcare Network In India Gets Massive Boost with Microsoft-Apollo Collaboration

According to Ki Mixon, a Partner at Resilience, TSS’s chief executive officer, Marc Drapp will continue to serve as CEO under Resilience Capital Partners’ ownership and Shirish Pareek, an industry veteran, who has over 20 years of experience in technology enabled and advanced global manufacturing will become the Executive Chairman of the company’s Board of Directors.   “Under both Marc and Shirish’s leadership we believe that TSS is well positioned for impressive strategic growth over the coming years and we look forward to our newest platform investment, which will focus on the growing trends in automation in both medical device and life science applications,” said Mixon.

Read More:  WORBLI Calls 2018 the Year of Substantive Growth in Blockchain and Predicts Global Expansion in 2019

Leave A Reply

Your email address will not be published.